Literature DB >> 647443

Recharacterization of fungal dinucleoside polyphosphate (HS3).

D R McNaughton, G R Klassen, P C Loewen, H B LéJohn.   

Abstract

Three polyphosphorylated dinucleosides given the pseudonyms of HS3, HS2, and HS1 that were erroneously described as diguanosine polyphosphates (LéJohn, H. B., Cameron, L. E., McNaughton, D. R. & Klassen, G. R. (1975) Biochem, Biophys, Res, Commun. 66, 460-467) have been repurified and partially recharacterized. They have proved to be extremely complex molecules; chemical (HCl and KOH hydrolysis), physical (ultraviolet-light spectral analysis and ion-exchange chromatography), and enzymic (nucleotide pyrophosphatase and bacterial alkaline phosphatase hydrolysis) studies showed that (i) all three HS compounds are uracil rich and (ii) only HS3 contains a purine nucleoside and glutamate. The partial structure of HS3 was deciphered as a moiety of ADP--sugar X--glutamate (the mode of attachment of glutamate is obscure) that is covalently linked to another moiety composed of UDP, mannitol, and four phosphates. Sugar X had chromatographic characteristics of ribitol, but the chromatographic isolate also contained a ninhydrin-sensitive entity presumed to be an amino group. Sugar X, THEREFore, may be an amino sugar polyol. Only the general chemical compositions of HS2 and HS1 were determined. Each contained two uridines and HS2 had 10 phosphates whereas HS1 had 12.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 647443     DOI: 10.1139/o78-036

Source DB:  PubMed          Journal:  Can J Biochem        ISSN: 0008-4018


  2 in total

1.  Determination of the role of polyphosphate in transport-coupled phosphorylation in the yeast Saccharomyces cerevisiae.

Authors:  J Schuddemat; C C Van Leeuwen; J J Plijter; P J Van den Broek; J Van Steveninck
Journal:  Antonie Van Leeuwenhoek       Date:  1990-04       Impact factor: 2.271

2.  The potential of nucleotide analogs as inhibitors of retroviruses and tumors.

Authors:  R K Robins
Journal:  Pharm Res       Date:  1984-01       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.